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Abstract
Background: Animal studies and a few human studies have shown a change in sodium channel
(NaCh) expression after inflammatory lesions, and this change is implicated in the generation of
pain states. We are using the extracted human tooth as a model system to study peripheral pain
mechanisms and here examine the expression of the Nav1.7 NaCh isoform in normal and painful
samples. Pulpal sections were labeled with antibodies against: 1) Nav1.7, N52 and PGP9.5, and 2)
Nav1.7, caspr (a paranodal protein used to identify nodes of Ranvier), and myelin basic protein
(MBP), and a z-series of optically-sectioned images were obtained with the confocal microscope.
Nav1.7-immunofluorescence was quantified in N52/PGP9.5-identified nerve fibers with NIH ImageJ
software, while Nav1.7 expression in myelinated fibers at caspr-identified nodal sites was evaluated
and further characterized as either typical or atypical as based on caspr-relationships.
Results: Results show a significant increase in nerve area with Nav1.7 expression within coronal
and radicular fiber bundles and increased expression at typical and atypical caspr-identified nodal
sites in painful samples. Painful samples also showed an augmentation of Nav1.7 within localized
areas that lacked MBP, including those associated with atypical caspr-identified sites, thus identifying
NaCh remodeling within demyelinating axons as the basis for a possible pulpal pain mechanism.
Conclusion: This study identifies the increased axonal expression and augmentation of Nav1.7 at
intact and remodeling/demyelinating nodes within the painful human dental pulp where these
changes may contribute to constant, increased evoked and spontaneous pain responses that
characterize the pain associated with toothache.
Background
The activation of voltage-gated sodium channels (NaChs)
plays an essential role in neuronal excitability, including
the initiation and propagation of action potentials [1].
Experimental animal studies and a few human studies
have shown that NaChs change their expression in sen-
sory neurons following inflammatory and nerve lesions
and these changes may contribute to the activation of pain
pathways leading to the development of increased pain
states [2].
The NaChs represent a diverse gene family, with at least
nine different isoforms identified within the mammalian
nervous system [3]. These different isoforms not only
show distinct electrophysiological properties but also
select distributions within different regions of the nervous
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system [4]. Much interest has been placed on the contri-
bution of isoforms preferentially expressed within the
peripheral nervous system to pain states. Although there is
evidence for the involvement of each of these isoforms in
nociception, the Nav1.7 isoform has recently been most
critically linked to pain in humans [4].
The human dental pulp is richly innervated by nociceptive
primary afferents [5] and represents a common site of
pathology and pain [6]. A common treatment modality
includes the extraction of the painful tooth, whereas nor-
mal wisdom teeth are also routinely extracted. Moreover,
pain characteristics can be documented prior to extrac-
tion, and together these features distinguish the use of the
human dental pulp as a model system to evaluate periph-
eral pain mechanisms. Here, we use this model system to
evaluate the expression of Nav1.7 within normal and
painful human pulpal specimens with the use of quanti-
tative methods and demonstrate increased axonal expres-
sion of Nav1.7 within axon bundles and at typical and
atypical nodal sites that showed alterations in myelin
staining relationships within painful samples.
Results
Qualitative description of Nav1.7 expression in N52/
PGP9.5-identified nerves
Nav1.7-immunofluorescence was observed in many nerve
fibers identified by N52/PGP9.5 staining in all regions of
both normal and painful dental pulp samples, including
fibers within the pulp horn (Fig. 1) and axon bundles
located throughout the pulp (Fig. 2). Fibers with Nav1.7
staining most commonly included those with both N52
and PGP9.5 (Figs. 1A–D and 2A,C). The N52/PGP9.5
staining (and especially the N52 staining) was mostly
seen within intact fibers in the normal samples (Fig. 2A),
but some normal samples (Fig. 2B) and most painful sam-
ples (Fig. 2C) also contained isolated fibers that appeared
fragmented. These fragmented fibers were generally inter-
mixed among intact ones located within axon bundles.
One painful sample contained only fragmented axons in
the coronal pulp (Figs. 1E,F) and these appeared very dif-
ferent than those isolated fragmented axons seen in some
normal (Fig. 2B) and most painful samples (Fig. 2C). The
expression of Nav1.7 was minimal in fibers with a frag-
mented appearance (Figs. 1E,F and 2C), while the expres-
sion within fibers with an intact appearance was seen in
different-sized fibers and included even staining of low
intensity and focal accumulations with brighter intensity.
Both of these staining patterns appeared more common in
painful samples (compare Figs. 2A to 2C). Three of the
painful samples contained localized areas within the mid-
dle of the coronal pulp with a high density of fibers with
prominent Nav1.7 staining, but with a diminished inten-
sity or even lack of N52/PGP9.5 staining within these
same fibers (Fig. 2D). The Nav1.7 expression within fibers
that lacked N52/PGP9.5 staining would not be evaluated
with the quantitative analysis described below. Since
increased numbers of accumulations with Nav1.7 were
seen in painful samples, adjacent sections of four sample
pairs were stained with caspr, a paranodal protein used to
identify nodes of Ranvier [7] and myelin basic protein
(MBP) antibodies for further characterization.
Quantitative analysis of Nav1.7 expression in N52/PGP9.5-
identified nerve area
Quantitative analysis showed no difference in the Nav1.7
expression within N52/PGP9.5-identified nerve area or in
the pixel intensity of this expression within axons in the
pulp horn of normal samples when compared to painful
samples (area – 57.6% ± 5.6 vs. 46.6% ± 11.9; Fig. 3A/
intensity – 549.6 ± 26.1 vs. 670.8 ± 204.7; Fig. 3B). In con-
trast, the nerve area occupied by Nav1.7-immunoreactivity
was significantly greater within axon bundles located in
the coronal (41.7% ± 4.8 vs. 66.5% ± 5.4; p < 0.01 – Fig.
3C) and the upper radicular (27.2% ± 5.5 vs. 66.0% ± 7.0;
p < 0.001 – Fig. 3E) regions of the painful samples, but
with no differences in pixel intensity in either of these
areas (coronal – 503.8 ± 28.2 vs. 600.2 ± 65.4; Fig. 3D/
upper radicular – 489.1± 63.4 vs. 564.8 ± 38.2; Fig. 3F).
Nav1.7 expression and characterization at caspr-identified 
nodal sites
Evaluation of pulpal tissue sections stained with caspr
allowed a characterization of Nav1.7 at caspr-identified
nodal sites that were classified as either typical or atypical
as based on caspr relationships (see Methods for details).
This analysis was limited to axon bundles within the coro-
nal and upper radicular regions of four normal and four
painful samples, since nodes are commonly seen in these
regions. This analysis was performed on images that were
thresholded to eliminate low intensity pixels while main-
taining those with higher immunofluorescence intensity,
since these are the ones typically seen at nodes of Ranvier
(Figs. 4A–D). The total number of nodal sites evaluated
was 2320 and included more than 500 sites in each region
in both normal and painful samples. This analysis
showed a dramatic increase in the percentage of nodal
sites with Nav1.7 expression in painful samples within
coronal and upper radicular regions (Figs. 4E,F). This
increased percentage of Nav1.7-positive nodal accumula-
tions within painful samples was seen at both typical
(coronal – 2.7% ± 1.5 vs. 35.3% ± 5.5; p < 0.01 – Fig. 4E/
upper radicular – 5.9% ± 2.7 vs. 32.7% ± 9.8; p < 0.05 –
Fig. 4F) and atypical (coronal – 6.9% ± 4.0 vs. 53.9% ±
11.1; p < 0.01 – Fig. 4E/upper radicular – 9.1% ± 5.5 vs.
59.8% ± 8.4; p < 0.01 – Fig. 4F) nodal sites. In addition,
there was a significant increase in the occurrence of atypi-
cal nodal forms within painful samples relative to the
total number of all caspr-identified sites (coronal – 11.0%
± 3.9 vs. 36.9% ± 7.7; p < 0.05 – Fig. 4G/upper radicularMolecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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– 9.9% ± 3.7 vs. 24.9% ± 4.6; p < 0.05 – Fig. 4H).
Together, these results identify the increased association
of Nav1.7 at both typical and atypical nodal sites and an
increased occurrence of atypical nodal forms within pain-
ful samples.
Myelin basic protein expression
Pulpal tissue sections that were triple-stained with Nav1.7,
caspr and MBP antibodies allowed a characterization of
Nav1.7 expression at typical and atypical nodal sites in
relation to state of myelination as reflected with the use of
the MBP antibody (Fig. 5). The expression of Nav1.7 in
normal samples was seen evenly distributed within small
fibers that lacked caspr and MBP staining and that most
likely represent unmyelinated fibers, while expression
within myelinated fibers with caspr and MBP stainings
was mostly confined to the nodal site of some fibers (Fig.
5A). The expression of MBP within normal samples was
prominent on the surface of fibers located within axon
bundles and less at nodal regions (Fig. 5A). In contrast,
this expression of MBP was altered in painful samples
(Fig. 5B,C). Alterations in MBP included generalized (Fig.
5B) and focal (Fig. 5C) decreases in expressions. General-
ized loss was seen in some fibers with typical nodes (Fig.
5B), while localized alterations included a loss of MBP in
the area adjacent to heminodes (Fig. 5B) and the axonal
region between split nodes (Fig. 5C). Typical and atypical
nodes that were associated with a generalized loss of MBP
staining (Fig. 5B) and the axonal area located between the
split nodes (Fig. 5C), both contained prominent Nav1.7-
Nav1.7 expression in pulp horn Figure 1
Nav1.7 expression in pulp horn. A-F. Confocal micrographs of single optical images showing Nav1.7 (red) expression 
within N52 (green) and PGP9.5 (blue)-identified nerve fibers within the pulp horn of one normal (A, B) and two painful (C-F) 
samples. A and B. Nav1.7 (arrow) is expressed in many nerve fibers in the normal pulp horn (A) that stain with N52 and 
PGP9.5 as seen in the combined image in B. C and D. The pulp horn from a painful sample also shows Nav1.7 expression 
(arrow) in most nerve fibers that stain with N52 and PGP9.5 as seen in the combined image in D. E and F. The pulp horn of 
one painful sample contains no Nav1.7 staining (E) within fibers that appear fragmented as visualized with N52 staining (F; 
arrows). Scale bars = 50 μm.Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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immunofluorescence. These findings are consistent with a
remodeling of NaChs in areas of demyelination as identi-
fied by a loss of MBP staining.
Discussion
The results of this study demonstrate both the axonal
expression of the Nav1.7 sodium channel (NaCh) isoform
within the normal human dental pulp and changes in the
expression of this isoform seen in painful samples. Quan-
titative methods showed an increased overall nerve fiber
expression of Nav1.7 within axonal bundles but with no
difference in expression within fibers located in the pulp
horn, while single fiber analysis of caspr-identified nodal
sites showed an increased expression of the isoform at typ-
Nav1.7 expression in axon bundles Figure 2
Nav1.7 expression in axon bundles. A-D. Confocal micrographs of single optical images showing Nav1.7 (red) expression 
within N52 (green) and PGP9.5 (blue)-identified nerve fibers within axon bundles in normal (A, B) and painful (C, D) samples. 
A and B. Nav1.7 (red; arrows) is expressed in nerve fibers that appear intact as visualized with PGP9.5 and especially N52 
(green) staining within an axon bundle located in a normal sample (A), while a different normal sample shows some fibers that 
appear fragmented as seen with N52 staining (B; arrow). C and D. The expression of Nav1.7 within a painful sample (C) 
appears prominent within intact nerve fibers (arrows), but less in fibers that appear fragmented (arrowheads) as visualized with 
N52 staining. A different painful sample contains many fibers with prominent Nav1.7 staining, including some that show minimal 
staining with N52 and PGP9.5 (D; arrow). Scale bars = 20 μm in A-C and 100 μm in D.Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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ical and atypical nodal sites. Additionally, the atypical
nodal sites were more common in painful samples and
were associated with areas where MBP staining was lost.
This pattern of MBP staining loss is similar to that found
in demyelinating diseases [8] and this finding suggests the
reorganization of NaChs at demyelinated sites as a pulpal
pain mechanism. Together, these findings are consistent
with a possible role for Nav1.7 in the constant, increased
evoked and spontaneous pain sensations that characterize
toothache and suggest the involvement of Nav1.7 as an
ion channel involved with human inflammatory pain
conditions. Furthermore, these changes are similar to
those seen after inflammatory nerve lesions and suggest
that pulpal pain mechanisms may include a neuroinflam-
matory neuropathic pain component.
The activation of voltage-gated NaChs is essential to
action potential initiation and propagation and changes
in expression may contribute to both inflammatory and
neuropathic pain mechanisms [2]. Although evidence
implicates the involvement of various NaCh isoforms in
this process, recent findings in humans identify a critical
role for the Nav1.7 isoform in pain sensation. These find-
ings include mutations that result in nonfunctional chan-
nels and the inability to perceive acute painful stimuli
[9,10], and point mutations that result in enhanced acti-
vation or impaired inactivation of channel current that are
found in subjects with two chronic pain conditions that
are characterized by burning-type pain [11,12].
The Nav1.7 isoform is prominently expressed within the
dorsal root ganglia in humans and experimental animals
[13,14] and especially in small diameter neurons that give
rise to C-fibers and that respond to nociceptive stimuli
[15]. Knockdown [16] and knockout [17] experiments
also link the involvement of Nav1.7 to inflammatory
hyperalgesia. Although these studies demonstrate a criti-
cal role for Nav1.7 in acute and inflammatory human
pain, contributions to neuropathic pain mechanisms are
less clear [18]. For example, the accumulation of Nav1.7
appeared greater in painful human neuromas when com-
pared to nonpainful ones [19], yet a quantitative evalua-
tion within human lingual nerve neuromas suggests that
Nav1.7 expression alone is not correlated with the pres-
ence of painful dysesthesia [20]. Even though carious
lesions of teeth result in pulpal pain that is most com-
monly thought to involve inflammatory mechanisms
[21], certain aspects of pulpal pain may result from neu-
ropathic pain processes that may contribute to the devel-
opment of spontaneous pain that is present in some cases
of toothache and that is a critical component of neuro-
pathic pain [22]. Therefore, evaluations of Nav1.7 expres-
sion within both normal and painful pulpal samples may
be useful to further our understanding regarding the role
of Nav1.7 to both peripheral human inflammatory and
neuropathic pain mechanisms.
The human dental pulp is richly innervated by nocicep-
tors that include significant and differential contributions
from both C-fibers and thinly myelinated fibers to dis-
crete regions within the pulp [23,24]. The pain associated
with irreversible pulpitis most likely involves contribu-
tions from both fiber types [25]. The pulpal expression of
Nav1.7 was present within small fibers that lacked caspr
(most likely representing C-fibers) and that are important
in mediating dull toothache sensations, while the
increased expression at nodal sites may be related to
sharp, shooting spontaneous pain that was present in our
patient population. Interestingly, many pulpal axons
expressed N52. This result is surprising given that unmy-
elinated afferents are common within the pulp and others
have shown little or no N52 expression in unmyelinated
afferents [26]. The prominent expression of N52 within
the pulp is even more intriguing given our finding that
demonstrates Nav1.7 expression in presumptive unmyeli-
nated fibers that lack markers (MBP and caspr) for myeli-
nated fibers. One possible explanation for this finding
includes an expression of Nav1.7 with N52 within the
unmyelinated segments of myelinated afferents as they
become free nerve endings. Furthermore, this broad
expression of N52 suggests a possible thinning of fibers
even before they enter the pulp and if so, this would over-
estimate the number of unmyelinated fibers reported
within the pulp [5]. Additional studies are needed to fur-
ther evaluate these staining relationships and the relative
contributions of myelinated and unmyelinated fibers to
overall pulpal innervation.
The presence of sharp, shooting spontaneous and espe-
cially lingering pain responses following sensory stimula-
tion represents an important transition from reversible
pulpitis to irreversible pulpitis and an important change
from a hyperalgesic state to an acute pain condition. The
changes seen within axon bundles in our painful sample
population may be associated with this transition to an
acute pain state. A noteworthy finding was that the pain-
ful samples showed an extensive small cell and most likely
inflammatory cell infiltrate within coronal regions of the
pulp that often surrounded intact fiber bundles, whereas
smaller incipient lesions were not seen (data not shown).
Since inclusion criteria for the painful group included the
presence of spontaneous and moderate-to-severe pain,
this finding suggests a correlation of extent of lesion with
the transition to an acute pain state. This finding also sug-
gests that pain severity due to pulpal disease involves
either a cumulative effect on many fibers or a more selec-
tive effect on fibers deeper within the pulp, rather than the
select activation of fibers located at the pulp periphery,
such as those found within the odontoblastic layer of theMolecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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Results of quantitative analyses of Nav1.7 expression within nerve fibers in normal and painful samples Figure 3
Results of quantitative analyses of Nav1.7 expression within nerve fibers in normal and painful samples. A-F. 
The nerve area and pixel intensity of Nav1.7 expression within N52/PGP9.5-identified nerve fibers was quantified within differ-
ent regions in normal and painful samples. A and B. The nerve area (A) and pixel intensity (B) of Nav1.7 expression was not 
significantly different within the pulp horns of normal and painful samples. C-F. The nerve area of Nav1.7 expression was signif-
icantly greater within coronal (C) and upper radicular (E) axon bundles in painful samples, but with no difference between nor-
mal and painful samples in pixel intensity within these same regions (D, F). ** = p < 0.01, *** = p < 0.001.Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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Nav1.7 expression at caspr-identified nodal sites Figure 4
Nav1.7 expression at caspr-identified nodal sites. A-D. Confocal micrographs of maximum-intensity z-projections (five 
z-sections with spacing increments of one μm) showing the expression of non-thresholded (A, B) and thresholded (C, D) 
Nav1.7 (red) immunofluorescence at caspr (green)-identified sites within axon bundles in normal (A, C) and painful (B, D) sam-
ples. Typical nodal forms (arrows) predominate in the normal sample (A, C) and one of these shows Nav1.7 expression located 
within the nodal gap (arrowhead). The painful sample (B, D) shows atypical nodal forms that include both heminodes (black 
arrows) and a split node (arrowhead). Many of these atypical nodal forms and some of the typical nodal forms (white arrows) 
are associated with Nav1.7. E and F. The expression of Nav1.7 at typical and atypical caspr-identified nodal sites was deter-
mined within axon bundles located in coronal and radicular regions in normal and painful samples. Results show a significant 
increase in the percent of both typical and atypical nodes that were associated with Nav1.7 within the coronal (E) and radicular 
(F) axon bundles in painful samples. G and H. All caspr-identified nodal sites were evaluated within axon bundles located in 
coronal and radicular regions in normal and painful samples and were classified as either typical or atypical. Results show a sig-
nificant increase in the percent of atypical nodal sites within the coronal (G) and radicular (H) axon bundles in painful samples. 
Scale bars = 20 μm; * = p < 0.05, ** p < 0.01.Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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Nav1.7 expression at caspr-identified nodal sites as related to state of myelination Figure 5
Nav1.7 expression at caspr-identified nodal sites as related to state of myelination. A-C. Confocal micrographs of 
collapsed z-projection images (five z-sections with spacing increments of one μm) showing Nav1.7 (red), caspr (green) and 
myelin basic protein (MBP; blue) staining relationships in one normal (A) and two painful (B and C) samples. A and B. The nor-
mal sample (A) shows the expression of MBP and caspr associated with some myelinated fibers (arrows), while this expression 
is absent in other smaller fibers that most likely lack myelin (arrowheads). The expression of Nav1.7 is prominent within the 
fibers that lack myelin. In contrast, the painful sample seen in (B) contains many fibers with prominent Nav1.7 expression at 
caspr-associated nodal sites (white arrows), but that show either alterations (arrowheads) or a lack of MBP staining altogether 
(black arrows). C. Combined and single channel images of Nav1.7, caspr, and MBP staining relationships seen in a painful sample 
showing the increased expression of Nav1.7 within an axon segment that is flanked on both sides with caspr and that lacks MBP 
(arrows), whereas Nav1.7 expression is less in the areas of this same axon where MBP expression is present (arrowheads). 
Scale bars = 20 μm.Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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pulp horn. It is possible that smaller lesions that are con-
fined to the highly innervated and more superficial
regions of the pulp such as the pulp horn may be more
important in hyperalgesic pain responses and even repar-
ative processes rather than the generation of acute and
especially severe pulpal pain sensations. The overall pat-
tern and extent of Nav1.7 expression seen in the painful
human dental pulp not only supports contributions to
this inflammatory pain condition, but also suggests the
involvement of specific fibers types to the transition from
a hyperalgesic to acute pulpitis pain state.
The increased incidence of atypical nodal forms seen in
our painful samples and the association of Nav1.7 with
these atypical nodal forms provides evidence for the
remodeling of NaChs at demyelinated sites as a pulpal
pain mechanism. Changes within myelinated fibers are
important since the pain of irreversible pulpitis includes
spontaneous and evoked pain responses characterized by
a sharp, shooting quality that are most likely mediated by
myelinated fibers. Many studies have demonstrated that a
disruption of myelin produces profound changes in NaCh
expression [27-30] and that heminodes and split nodes
result from segmental and paranodal demyelination,
respectively [31]. Areas of demyelination are characterized
by a loss of myelin staining as identified with antibodies
against MBP [8], myelin oligodendrocyte glycoprotein
[32] and myelin-associated glycoprotein [31], with a pat-
tern that is similar to that identified in the present study.
Together these findings suggest that demyelinating influ-
ences exist in the inflamed dental pulp and that the reor-
ganization of ion channels at these sites may contribute to
activation of pulpal nociceptors. Although significant
demyelination of axons can lead to conduction loss,
demyelinating diseases that affect the peripheral and cen-
tral nervous systems are often times associated with pain
[33,34]. It is possible that conduction loss may represent
an advanced disease stage, while more subtle and local-
ized regions of demyelination could contribute to the acti-
vation of nociceptors and pain due to ion channel
remodeling within these sites. Certainly the immune sys-
tem response and the effect of this response on glia that
provide important molecular signals that influence ion
channel localization within axons, are all involved [35].
Further studies are needed to more fully understand the
complexities of these immune-glial-neuronal interactions
and their contributions to the development of an acute
pain state.
The physiological implications related to the increased
expression of Nav1.7 within the painful human dental
pulp are unknown but most likely relate to increased neu-
ronal excitability. Also unknown is the contribution of
increased Nav1.7 expression at typical and atypical nodal
sites to nerve activity and the pain experience. It is possi-
ble that the decreased expression of N52 seen in some fib-
ers is associated with a degenerative response that leaves
the fibers incapable of action potential propagation, but
even so, more proximal portions of these fibers may
remain physiologically active. One of the important find-
ings in our study that may address this issue was the com-
mon occurrence of these forms in painful samples. These
changes were not limited to areas adjacent to inflamma-
tory lesions but rather were also seen at more distant sites
(such as axon bundles in the radicular pulp). Neuronal
changes seen within the diseased pulp must be critical to
the pain experience since pulp removal or extraction of
the tooth is typically highly effective in the rapid elimina-
tion of the pain. This finding suggests activation of nocic-
eptors within diseased tissues is of clinical importance in
acute pain conditions and strengthens the usefulness of
single fiber analysis within peripheral tissues as possibly
even more important than changes within other levels of
the neuroaxis such as the neuronal cell body or central
axon terminals. However, in some cases, endodontic ther-
apy or tooth removal does not eliminate the pain and the
pain becomes chronic [36] and in these cases changes at
other levels are most certainly important.
Local anesthesia failures represent a major challenge to
the practice of painless dentistry. Although these failures
occur with the delivery of routine restorative procedures,
the incidence increases dramatically when treating painful
teeth with a diagnosis of irreversible pulpitis [37]. Since
local anesthetics target NaChs, this increased incidence
may include a change in NaCh expression. If a change in
NaCh expression is responsible for this phenomenon, the
change must be widespread along nerve fibers that inner-
vate these teeth since local anesthesia failures are also seen
where nerve blocks are performed at sites distant from the
site of disease. Even so, local anesthesia failures may
involve an increased density of NaChs that possibly
includes an increase in isoforms that are more resistant to
commonly used local anesthetics such as lidocaine.
Although earlier reports suggested that the tetrodotoxin
(TTX)-resistant NaCh isoforms may be less sensitive to
local anesthetics [38], other evidence suggests the oppo-
site, since TTX-resistant NaCh (including Nav1.8) currents
appear to be more sensitive to lidocaine than TTX-sensi-
tive forms such as Nav1.7 [39,40]. The increased expres-
sion of Nav1.7 within axon bundles of painful samples
and the decreased effectiveness of lidocaine on TTX-sensi-
tive NaCh isoforms, both suggest the possible involve-
ment of Nav1.7 in local anesthesia failures. Although this
possibility is appealing, a critical analysis of NaCh expres-
sion at more distant sites that correspond to areas where
local anesthetics are typically applied would be necessary
to more fully test this hypothesis.Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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Finally, the identification of atypical nodal forms within
axons in the painful human tooth with an inflammatory
lesion is similar to those seen in an experimental animal
model for inflammatory neuropathic pain [41]. This pro-
vides evidence for neuroinflammatory influences in the
genesis of toothache pain and furthermore suggests simi-
lar mechanisms may exist among certain chronic inflam-
matory and especially those neuropathic pain conditions
that often have an inflammatory component [42]. It has
even been suggested that a treatment modality for neuro-
pathic pain following peripheral nerve injury may include
the excision of the injured nerve, somewhat akin to pulp
removal or extraction of the offending tooth [43]. In this
regard, additional studies of the painful human dental
pulp represent an important target to further our under-
standing of both inflammatory and neuropathic pain
mechanisms.
Conclusion
Our findings identify increased axonal expression of
Nav1.7 within the painful human dental pulp that
includes an increased expression at intact and remode-
ling/demyelinating nodal sites. These changes suggest
contributions of Nav1.7 to the constant, increased evoked
and spontaneous pain sensations that characterize tooth-
ache pain and to other acute and chronic inflammatory
and neuropathic pain conditions.
Methods
Sample collection and tissue processing
This study was approved by the Human Subjects Institu-
tional Review Board at the University of Texas Health Sci-
ence Center at San Antonio and informed consent was
obtained from all subjects who participated in the study.
Teeth were obtained from subjects having an extraction of
a normal, nonpainful third molar with fully formed api-
ces (n = 13; 10 females and 3 males with an age range of
19–47), or a painful molar tooth diagnosed with irrevers-
ible pulpitis (n = 13; 10 females and 3 males with an age
range of 24–49). Painful samples were limited to those
that were associated with self-reports of moderate-to-
severe levels of pain severity and the presence of sponta-
neous pain episodes as rated over the 24 hour time-period
preceding the extraction. All painful teeth had the pres-
ence of a carious lesion that extended into the pulpal tis-
sues, whereas those with large necrotic pulpal lesions were
excluded.
Extracted teeth were collected in 0.1 M phosphate buffer
(PB) and stored at 4°C. Later the same day, the teeth were
split longitudinally and the pulpal tissues were removed
and fixed in 4% paraformaldehyde in 0.1 M PB for 20
minutes. The pulpal tissue was rinsed in 0.1 M PB and
then placed in 30% sucrose in 0.1 M PB overnight at 4°C.
The next day the pulp was placed in Neg-50 (Richard-
Allan Scientific; Kalamazoo, MI) and stored at -80°C. Pul-
pal samples were thawed and embedded in Neg-50, with
a normal sample next to a painful sample, and serially sec-
tioned with a cryostat at 30 µms in the longitudinal plane.
Sections were placed onto Superfrost Plus slides (Fisher
Scientific, Pittsburgh, PA), air dried and then stored at -
20°C.
Immunocytochemistry
Primary antibodies: rabbit polyclonal anti-Nav1.7 [13]
(produced against a 15 amino acid sequence in the rat
that shows 13/15 similarities with the human sequence,
1:100 for caspr analysis and 1:200 for nerve area analysis),
mouse monoclonal anti-neurofilament 200 kD (N52,
Sigma-Aldrich, St. Louis, MO, catalog #N0142, 1:2000),
guinea-pig polyclonal anti-protein gene product 9.5
(PGP9.5, Chemicon, Temecula, CA, catalog # AB5898,
1:300), mouse monoclonal anti-caspr (developed by and/
or obtained from the UC Davis/NINDS/NIMH Neuromab
Facility, supported by NIH grant U24NS050606 and
maintained by the Department of Pharmacology, School
of Medicine, University of California, Davis, CA 95616,
catalog #75-001, 1:500), rat monoclonal anti-myelin
basic protein (MBP; Chemicon, Temecula, CA, catalog
#MAB386 1:200). Secondary antibodies: Alexa Fluor® 568
goat anti-rabbit IgG, Alexa Fluor® 488 goat anti-mouse
IgG, Alexa Fluor® 633 goat anti-rat IgG and goat anti-
guinea-pig IgG (all from Molecular Probes, Eugene, OR).
All secondary antibodies were used at 1:100.
Immunostaining was performed as described previously
[44]. Briefly, tissue sections were permeabilized and
blocked for non-specific protein binding sites with block-
ing solution consisting of 4% normal goat serum (Sigma),
2% bovine gamma-globulin (Sigma), and 0.3% Triton X-
100 (Fisher Scientific) in PBS for 90 minutes prior to the
incubation with primary antibodies in blocking solution
for 16 hours. One section from each normal/painful pair
was stained with Nav1.7/N52/PGP9.5, while the adjacent
section from select sample pairs were stained with Nav1.7/
caspr/MBP. Sections were rinsed with PBS, incubated in
secondary antibody in blocking solution for 90 minutes,
rinsed in PBS and ddH2O, dried, and coverslipped with
Vectashield (Vector Laboratories, Burlingame, CA). All
procedures were performed at room temperature.
Confocal microscopic evaluation and image acquisition
Sections were evaluated with a Nikon Eclipse 90i C1si
laser scanning confocal microscope with a 40×/1.30 N.A.
oil immersion objective. This evaluation included the
selection of a laser gain setting used to image Nav1.7-
immunofluorescence to avoid saturated pixels so to allow
a full dynamic range of Nav1.7-immunofluorescence pixel
intensity and to select laser gain settings used to image all
other primary antibodies. A series of optical images at 6Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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µm increments along the "z" axis of the sections stained
with Nav1.7/N52/PGP9.5 antibodies were acquired from
the middle 18 µm of each 30 µm thick section in the pulp
horn and axon bundles in the coronal and radicular
regions when present. Images obtained from the pulp
horn in painful samples included only those areas where
inflammatory cells were seen nearby to fibers. Care was
taken to select fiber bundles that showed N52/PGP9.5
staining within intact fibers, since extensively fragmented
fibers may represent degenerating ones. These selection
criteria allowed the collection of a z-series of optical
images from the pulp horn in 8 normal and 6 painful
samples, coronal axon bundles in 12 normal and 8 pain-
ful samples, and radicular axon bundles in 8 normal and
8 painful samples. A z-series of optical images were also
obtained at 1 µm increments from the middle 20 µm of
the 30 µm thick sections of coronal and radicular axon
bundles in four normal and four painful samples stained
with Nav1.7/caspr/MBP antibodies. All images were cap-
tured with identical settings (including laser gain settings)
at a 1024 × 1024 resolution (where each pixel is ? 0.3 µm
width with an area ? 0.09 µm2) and saved as 12 bit single-
channel images with a 0–4095 range of pixel intensities.
Images were processed for illustration purposes by using
Adobe Photoshop CS2 (Adobe Systems, San Jose, CA) and
CorelDRAW 12 (Corel Corporation, Ottawa, Canada).
Control tissue specimens were processed as above except
the undiluted Nav1.7 antibody was preincubated with
peptide antigen (approximately 30:1 peptide to antibody
molar concentration ratio) for a minimum of 4 hours
before application of the peptide-blocked antibody. Addi-
tional control specimens lacked the application of pri-
mary antibodies. Control sections lacked specific
immunofluorescence.
Quantitative and image analyses
The specimens stained with the Nav1.7/N52/PGP9.5 anti-
bodies were used to evaluate Nav1.7 expression within
N52 and PGP9.5 identified nerve fibers. Each individual
channel was opened with NIH ImageJ software [45] with
the use of the ICS Opener plug-in [46]. The corresponding
PGP9.5 and N-52 z-slices were combined by using the
"Max Operation" in the Image Calculator. The staining
intensities in all images were filtered by applying a thresh-
old value to remove low intensity pixels that represent
nonspecific/background values. The threshold value was
determined with mean and standard deviation pixel
intensity values obtained from a histogram analysis of
every Nav1.7 and combined N52/PGP9.5 image slice from
normal samples. Average values for mean and standard
deviation pixel intensities were then obtained independ-
ently for the Nav1.7 and combined N52/PGP9.5 groups,
and then a threshold value (mean + 2 times the standard
deviation) for each group was applied to remove (filter)
background staining. This thresholding process was
applied in a consistent manner to all images from the nor-
mal and painful sample groups and resulted in images in
which N52/PGP9.5 staining was clearly limited to nerve
fibers. The thresholded nerve fiber area was recorded by
creating a selection in every slice and this was saved as a
region of interest (ROI). The nerve area ROI was trans-
posed onto the corresponding thresholded Nav1.7 image.
The thresholded image was then redirected to the original
Nav1.7 image so that when it was analyzed, the actual
Nav1.7-immunofluorescence pixel intensities within the
ROI were recorded. The particles were then analyzed, and
the average intensity and percent area of nerve fiber occu-
pied by Nav1.7 were recorded.
The Nav1.7 expression within single fibers at caspr-identi-
fied nodal sites that were classified as either typical or
atypical were determined in the z-series of images that
were obtained in sections stained with the Nav1.7 and
caspr antibodies. The typical nodal sites were identified by
extensive caspr staining within two bands that were sepa-
rated by a nodal gap, while any deviations from this rela-
tionship were classified as atypical nodal sites. The most
common caspr-identified atypical nodal site included
heminodes that were identified as a single band of caspr
staining, or two bands of caspr staining separated by a
nodal gap but where the area of caspr staining was greatly
diminished on one side to less than 50% of that seen on
the side with more extensive caspr staining. All caspr-iden-
tified sites within single fibers were classified in each z-
series image stack with navigation through each stack to
clarify relationships, while the Nav1.7 expression at indi-
vidual nodal sites was performed on maximum intensity
collapsed z-projection images generated from each z-
series. The Nav1.7-immunofluorescence pixel intensity in
each collapsed image was filtered by applying a threshold
value to remove low intensity pixels while leaving pixels
with higher immunofluorescence intensity like those
located within nodal accumulations. A threshold value for
Nav1.7 staining was determined with mean and standard
deviation pixel intensity values obtained from a histo-
gram analysis of the single-channel Nav1.7-only maxi-
mum projection from each of the four normal tooth pulp
samples. Mean values were calculated, and a threshold
value (mean + six times the standard deviation) was
applied to each maximum intensity collapsed z-projec-
tion image. All caspr-identified nodal sites were included
in the analysis and Nav1.7-positive nodal sites were
defined as those accumulations with one or more Nav1.7-
positive pixel(s) above threshold that were clearly associ-
ated with caspr staining as confirmed with identification
of the same nodal site in the appropriate z-series image
stack. This analysis was limited to caspr-identified sites
located within fibers that were fully represented within
the z-series image stack. All nodal accumulations were
classified as either typical, or atypical and further classi-Molecular Pain 2008, 4:16 http://www.molecularpain.com/content/4/1/16
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fied as associated with Nav1.7 or as lacking this associa-
tion. This evaluation further allowed the characterization
of Nav1.7 at some caspr-identified atypical sites that were
classified as split nodes where two distinct Nav1.7 accu-
mulations were separated by a gap in the Nav1.7 staining
within the same fiber and with each Nav1.7 accumulation
being flanked on only one side by caspr.
Statistical analysis
Statistical analysis to determine significance used the
unpaired Student t-test while error bars on all graphs rep-
resent the standard error of the mean (SEM). The "n" val-
ues used in all instances represented the number of
samples evaluated.
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